Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ludger Klimek, Moritz Gröger, Sven Becker

    Laryngo- Rhino- Otologie
    |January 5, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Allergic rhinitis (AR), affecting 20% of people, is often caused by mite allergies. Treatment involves allergen avoidance, medications like antihistamines and nasal steroids, and allergen-specific immunotherapy for a causal approach.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Surgical Management of Non-Allergic Rhinitis-An EAACI Task Force Position Paper.

    Allergy·2026
    Same author

    Allergic rhinitis in the elderly. In collaboration with ARIA guidelines.

    The journal of allergy and clinical immunology. In practice·2026
    Same author

    Estimating work-related indirect costs in allergic rhinitis and asthma using a daily combined symptom-medication score: a MASK-air® study in collaboration with the EAACI Methodology Committee.

    The journal of allergy and clinical immunology. In practice·2026
    Same author

    [Documentation of biological treatment in asthma].

    Pneumologie (Stuttgart, Germany)·2026
    Same author

    Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
    Same author

    Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes.

    The World Allergy Organization journal·2026
    Same journal

    Laryngo- rhino- otologie·2026
    Same journal

    Laryngo- rhino- otologie·2026
    Same journal

    Laryngo- rhino- otologie·2026
    Same journal

    [Otitis media - update on clinical presentation, diagnosis and therapy].

    Laryngo- rhino- otologie·2026
    Same journal

    [Diagnostic error "acute otitis media"].

    Laryngo- rhino- otologie·2026
    Same journal

    [Pharyngeal high‑resolution manometry: techniques and applications].

    Laryngo- rhino- otologie·2026
    See all related articles

    Area of Science:

    • Allergy and Immunology
    • Otolaryngology

    Background:

    • Allergic rhinitis (AR) impacts approximately 20% of the global population.
    • Mite allergy is a significant cause of perennial rhinitis, affecting one-third of AR patients.
    • Perennial rhinitis frequently co-occurs with other allergic conditions like asthma and atopic dermatitis.

    Purpose of the Study:

    • To review the diagnosis and management of perennial allergic rhinitis caused by mite allergy.
    • To highlight the importance of anti-inflammatory activity in treatment strategies.
    • To discuss current therapeutic options, including pharmacological and causal treatments.

    Main Methods:

    • Literature review of diagnostic challenges and therapeutic strategies for mite-induced perennial allergic rhinitis.
    • Analysis of drug classes used in managing mite-AR, focusing on anti-inflammatory effects.

    Related Experiment Videos

  • Evaluation of allergen avoidance and allergen-specific immunotherapy as treatment modalities.

    • Main Results:

    • Non-specific symptoms and insidious onset can complicate AR diagnosis.
    • Effective management includes environmental controls, encasings, and personal actions.
    • Pharmacological treatments comprise mast cell stabilizers, H1-antihistamines, topical nasal glucocorticosteroids (GCS), leukotriene receptor antagonists, and decongestants.

    Conclusions:

    • A combination of H1-antihistamine and topical nasal GCS offers a rational anti-inflammatory approach for mite-AR.
    • Allergen-specific immunotherapy represents the only causal treatment option alongside allergen avoidance.
    • Comprehensive management strategies are crucial for patients with perennial rhinitis and associated comorbidities.